Pharmaceutical Industry News Archive
Get news by email or subscribe to our news feeds.
News Archive for May 2008
May 1, 2008
- Sepracor to Acquire Oryx Pharmaceuticals Inc. and Expand Commercial Operations into Canada
- Eisai Gained Favourable Ruling by Court of Appeal, as NICE Process for Developing Guidance on Anti-dementia Medicines Ruled Unfair
- NUCRYST Announces Management Realignment and R&D Portfolio Change
- Abbott, Takeda Conclude TAP Joint Venture
- SEC Charges McCann-Erickson Worldwide With Accounting Fraud
- Interpublic Announces Agreement to Settle SEC Claims
- 'Sharing Miracles' Television Program to Feature Leave it to Beaver Star Jerry Mathers
- Renovis Stockholders Approve Acquisition by Evotec
May 2, 2008
- Roche Exercises its Option to Further Develop and Commercialize Memory Pharmaceuticals' Nicotinic Alpha-7 Agonist, MEM 3454
- QSV Biologics Awarded cGMP Manufacturing Contract by Pfizer Inc.
- Merck Extends Enrollment Deadline in Program to Resolve U.S. Vioxx Product Liability Lawsuits
- Critical Therapeutics Signs Definitive Agreement to Merge with Cornerstone BioPharma
May 5, 2008
- Nordic Capital Fund VII and Avista Capital Partners Agree to Acquire ConvaTec Business for approximately $4.1 Billion
- Curis Announces Genentech's Initiation of Hedgehog Antagonist Phase II Clinical Trial In Metastatic Colorectal Cancer
- VaxGen Sells Anthrax Vaccine Program and Related Assets and Technology to Emergent BioSolutions, Inc.
- GE Healthcare Signs Global Molecular Diagnostic Agreement to Advance Respiratory Drug Development
May 6, 2008
- Merck to Reduce U.S. Sales Force by 1,200 Positions
- Bayer Schering Pharma to Market New Low-dose Oral Contraceptive Yaz in Europe
- Teva Reports First Quarter 2008 Results
- EPO Announces Symbicort European COPD Use Patent Decision
- Fougera First-to-Market With Calcipotriene Topical Solution 0.005% (Rx) (Scalp Solution)
- Stiefel Laboratories, Inc. Acquires ABR Invent and ABR Development
May 7, 2008
- Enzon Pharmaceuticals, Inc. Announces Plan to Spin-off Biotechnology Business
- ACT Biotech Acquires Clinical and Early Stage Oncology Portfolio Licenses From Bayer Healthcare
- Quintiles Signs Agreement to Acquire Eidetics
May 8, 2008
- King Pharmaceuticals Reports First-Quarter 2008 Financial Results
- Biovail Announces New Strategic Focus
- Novartis Exercises Rights to Purchase Additional Shares of Alnylam's Common Stock in Accordance with Terms of Existing Investor Rights Agreement
- GAO Report: Prescription Drugs - Trends in FDA’s Oversight of Direct-to-Consumer Advertising
- FDA Sends Letter to Shire Over Fosrenol Promotional Materials
- FDA Sends Novartis Warning Letter Over Trileptal Promotional Materials.
May 9, 2008
- Orion has decided not to continue the development of a new COMT inhibitor candidate
- Schweizerhall: Impending Approval of Clopidogrel from Cimex in Germany
- Takeda Sees Operating Profit Drop for 2nd Yr on Swelling Costs
- Lancet: Combating Counterfeit Drugs
May 12, 2008
- Forest Laboratories, Inc. and Daiichi Sankyo, Inc. Announce the Termination of the Azor Co-Promotion Agreement
- Lilly Completes Final Phase of Its Indianapolis Biotechnology Complex
- Walgreens Health Initiatives Reports Negative Drug Trend for Highly Managed Plans
May 13, 2008
- Pharmexa Stops One of Two Phase III Trials
- Palatin Technologies Announces New Strategic Objectives and Reports Third Quarter 2008 Financial Results
- Daiichi Sankyo: Expansion of Business into Turkey and India
- Lilly Partners With TopCoder, to Find Drug Discovery IT Solutions
- Higher Risk of Death and Stroke in Patients Given Beta-Blockers After Non-Cardiac Surgery (POISE Trial)
- Bristol-Myers Squibb and KAI Pharmaceuticals Enter Global Alliance to Develop and Commercialize KAI-9803 for Cardiovascular Disease
- Angiotech appoints Hank McKinnell to its Board of Directors
- Lilly Backs Federal Legislation to Inform the Public on Payments to Physicians
May 14, 2008
- Chronic Medication Nation: Research Finds Chronic Health Problems Now Afflict More Than Half of All Americans
- Takeda Completes Subsequent Offering Period for Shares of Millennium Pharmaceuticals, Inc.
- Securities Class Action Against Discovery Labs is Dismissed
- Sosei Announces Outcome of Strategy Review
- Mylan Launches Paroxetine Hydrochloride Extended-Release Tablets
- Takeda Completes Acquisition of Millennium
- FDA Places Geron's GRNOPC1 IND on Clinical Hold
- FDA releases a Follow-up to the November 14, 2007, Communication about the Ongoing Safety Review of Cefepime (marketed as Maxipime)
- Merck Wins Appeal in Vioxx Case
May 15, 2008
- Manufacturer Removes Remaining Stocks of Trasylol
- IMS Health Forecasts Continued Double-Digit Annual Growth of Cancer Therapeutics: Global Sales Expected to Exceed $75 Billion by 2012
- Diabetes Drugs Emerge as Top Force in Drug Spending Growth
- Biovitrum AB (SE) - Biovitrum Implements Strategic Restructuring of the R&D Organization
- Forbes Medi-Tech Announces Corporate Restructuring --Company To Focus Exclusively on Core Nutraceutical Business and Reduce 2008 Research and Development Expenses by Approximately $2.7 Million-
- Ortho Biotech, L.P. and Centocor, Inc. Alert Authorized Distributors and Prescribing Physicians About Stolen Product
- District Court Decision Affirmed in U.S. Lovenox (enoxaparin sodium) Patent Infringement Case
May 16, 2008
- American Red Cross Vindicated in J&J Lawsuit
- Statement - New CIHI Report shows value of new medicines in health care system, Rx&D
- Antisoma plc (UK) - Antisoma to Acquire Boston-Based Xanthus Pharmaceuticals
- Celebrex Shows Benefit In First-of-Its-Kind Lung Cancer Chemoprevention Trial
- Biovail Subsidiary Reaches Settlement with United States Department of Justice
- Information on Mycophenolate Mofetil (marketed as CellCept) and Mycophenolic Acid (marketed as Myfortic)
May 19, 2008
- Intellect Neurosciences, Inc. Grants License for Certain Patents and Patent Applications to Wyeth and Elan Pharma International Ltd.
- Ipsen and Medicis Announce Acceptance of Reloxin BLA in Aesthetics by FDA
- Biogen Idec Celebrates 30 Years of Transforming Discovery into Care
- Customs: Commission Publishes 2007 Customs Seizures of Counterfeit Goods at the EU's External Border
May 20, 2008
- Record Venture Capital and Heated Deal Environment Propel Global Biotechnology Industry Forward in 2007
- Global Menopause Summit Concludes HRT is Safe for Healthy Women Entering Menopause
- FivePrime and Pfizer Enter Oncology and Diabetes Collaboration
May 21, 2008
- Daiichi Sankyo Co., Ltd. Announces Acquisition of Biotech Firm U3 Pharma AG
- ACHIEVE Imaging Study Discontinued
- Reps. Dingell, Stupak Request Improved Accuracy, Stronger Guidelines for DTC Ads
- Lilly Announces Changes in Key Leadership Roles
May 22, 2008
- FTC’s Bureau of Competition Issues FY 2007 Summary of Pharmaceutical Company Settlement Agreements
- Amgen Posts Medical Education and Foundation Grants and Donations as Part of the Company's 'Clearly Amgen' Initiative
- ThalesNano Inc. and sanofi-aventis R&D Collaborate on Continuous Process Chemistry in Order to Dramatically Reduce Drug Realization Time
- AstraZeneca Supports Transparency Legislation on Payments to Health Care Providers
- eHealth Initiative's Drug Safety Collaboration to Partner With FDA on Sentinel Initiative
- New Efforts to Help Improve Medical Products for Patient Safety and Quality of Medical Care
May 27, 2008
- Migenix Takes Operational Actions To Extend Cash Past Upcoming Key Milestones
- Alnylam and Takeda Form Strategic Worldwide Platform Alliance in RNAi Therapeutics
- Santarus Achieves $2.5 Million Regulatory Milestone under OTC License Agreement with Schering-Plough
- Short-Term Use of Antipsychotics in Older Adults with Dementia Linked to Serious Adverse Events
May 28, 2008
- Taro Terminates Merger Agreement with Sun Pharmaceutical Industries Ltd.
- Statement on Third-party Clopidogrel Applications in Germany
- Pfizer Names Amy W. Schulman as Senior Vice President and General Counsel
- Westaim Updates Shareholders on Strategic Alternatives
- Boston Scientific Announces Court Decision
- Pharma Companies Integrate Customer Service Portals for Physicians into the Marketing Mix
- Australian Full Federal Court Upholds Basic Lipitor Patent, Preventing Launch of Generic Ranbaxy Product
- Schweizerhall: Clopidogrel From Cimex Approved in Germany
May 29, 2008
- Favrille Announces Workforce Reduction
- Sun Pharma responds to Taro's purported termination of merger agreement
- Bristol-Myers Squibb to Acquire Kosan Biosciences
- Merck Wins Appeal of First Vioxx Case to Go to Trial
- Merck Wins Appeal of First Vioxx Case to go to Trial
- Cardiovascular Meds May Be Beneficial in Alzheimer's Disease, According to MedPredict Report
- Assembly on the Move for Rx Reform
- The Lanier Law Firm Will Appeal Court Reversal of Jury Award to Widow in Nation's 1st Vioxx Trial
